- Home
- ACIU vs RMBI Comparison
ACIU vs RMBI Comparison
Compare ACIU & RMBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACIU
- RMBI
- Stock Information
- Founded
- ACIU 2003
- RMBI 1887
- Country
- ACIU Switzerland
- RMBI United States
- Employees
- ACIU N/A
- RMBI N/A
- Industry
- ACIU Biotechnology: Pharmaceutical Preparations
- RMBI Major Banks
- Sector
- ACIU Health Care
- RMBI Finance
- Exchange
- ACIU Nasdaq
- RMBI Nasdaq
- Market Cap
- ACIU 168.7M
- RMBI 139.1M
- IPO Year
- ACIU 2016
- RMBI 2019
- Fundamental
- Price
- ACIU $1.73
- RMBI $12.96
- Analyst Decision
- ACIU Strong Buy
- RMBI
- Analyst Count
- ACIU 2
- RMBI 0
- Target Price
- ACIU $10.00
- RMBI N/A
- AVG Volume (30 Days)
- ACIU 103.2K
- RMBI 37.1K
- Earning Date
- ACIU 08-05-2025
- RMBI 07-24-2025
- Dividend Yield
- ACIU N/A
- RMBI 4.61%
- EPS Growth
- ACIU N/A
- RMBI 2.54
- EPS
- ACIU N/A
- RMBI 0.89
- Revenue
- ACIU $32,014,254.00
- RMBI $42,825,687.00
- Revenue This Year
- ACIU N/A
- RMBI N/A
- Revenue Next Year
- ACIU $533.21
- RMBI N/A
- P/E Ratio
- ACIU N/A
- RMBI $14.71
- Revenue Growth
- ACIU 91.20
- RMBI 2.64
- 52 Week Low
- ACIU $1.43
- RMBI $11.26
- 52 Week High
- ACIU $4.98
- RMBI $15.15
- Technical
- Relative Strength Index (RSI)
- ACIU 54.55
- RMBI 37.53
- Support Level
- ACIU $1.60
- RMBI $13.00
- Resistance Level
- ACIU $1.82
- RMBI $13.75
- Average True Range (ATR)
- ACIU 0.10
- RMBI 0.42
- MACD
- ACIU 0.01
- RMBI -0.14
- Stochastic Oscillator
- ACIU 65.38
- RMBI 3.99
About ACIU AC Immune SA
AC Immune SA is a clinical-stage biopharmaceutical company that focuses on neurodegenerative diseases. The company uses its proprietary technology platforms to discover, design, and develop novel proprietary small molecules, antibodies, and vaccines for the prevention, diagnosis, and treatment of neurodegenerative diseases associated with protein misfolding. The Company has one segment. The Company currently focuses most of its resources on discovering and developing therapeutic and diagnostic products targeting misfolded proteins. The company's pipeline consists of ACI-24.060, Crenezumab, ACI-35.030, Semorinemab, ACI-7104.056, and others.
About RMBI Richmond Mutual Bancorporation Inc.
Richmond Mutual Bancorp Inc is a United States-based banking company. Its principal business consists of attracting deposits from the general public & brokered deposits and investing those funds predominantly in loans secured by commercial and multi-family real estate, first mortgages on owner-occupied, one-to four-family residences, a variety of consumer loans, direct financing leases, and commercial and industrial loans. The company has one reportable segment which is Community Banking.